Zeon Lifescience Plans To Foray Into Medical Nutritional Sector

The leading nutraceutical company Zeon Lifescience said that it is planning to foray into the medical nutritional sector and expecting its turnover of INR 400 crore this year which was 230 crore during previous year.

“This year, the company is focusing on rolling out medical nutritional and science based products including anti-cancer, anti-diabetic, and women healthcare. We have focused this year on these type of products. We also have joint ventures with some universities where we will get a lot of ideas and we will work on these ideas and convert into the commercials,” Garg said in an interview.

“All the major pharma companies these days are looking after to the nutraceutical industry,” he said adding that the company is expecting the turnover of INR 400 crore this year as compared to INR 230 crore in previous year.

Talking further about the impact of pandemic on the functioning of the company, he said the business is increasing day by day and as far as pandemic is concerned, it has not affected the industry.

“We are one of the leading nutraceutical company and business is increasing every day. Pandemic solely given the uncertainty to the businesses but fortunately nutraceutical business which has given the wellness to everybody, has not been affected. Even amid the restrictions imposed by the government, we have maintained the production standards. We also did not give any layoff to any employee because of the restrictions of the government and thinking of wellbeing of our employees,” Suresh Garg, Founder and Managing Director of Zeon Lifescience told Opportunity India.

On asking about any fundraiser for the further scaling up of the company the founder said that it is working on some projects of which production might start next year and for that company is considering the thoughts of investment for the project and how it will be executed in the future but there is not such announcement as of yet.

Suggesting budding entrepreneur about the opportunity in the nutraceutical industry, Garg said that the industry is very attractive and there is big scope for the businesses.

“This industry is the most attractive industry and it is only 2 per cent in India as compared to the global level. There is very big scope in health and wellness industry to work on. There are different type of technologies in this field which can help entrepreneur in their businesses,” he said.

Talking about the inflation he said, “We are facing the problem of getting raw material even after paying the higher charges due to which overall cost of the products has been increased. Few materials which we get from countries like US has become 30 to 40 per cent costlier due to the inflation,” he said.

Zeon Lifescience was incorporated in 1987 and is majorly in manufacturing (nutraceuticals) business from last 35 years and currently. The company has emerged as a leader in contract manufacturing for nutraceuticals and herbal products leading the company to boundaries beyond the horizon.